Mechanism of Action: Cytochrome P450 2D6 Inhibitors
✉ Email this page to a colleague
Drugs with Mechanism of Action: Cytochrome P450 2D6 Inhibitors
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novugen | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 215947-002 | Jan 5, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Qilu | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 212462-002 | Jun 25, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208446-002 | Dec 14, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Florida | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 215086-001 | Mar 23, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Msn | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 210686-001 | Jul 10, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Rising | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208371-001 | Feb 25, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
